Immunoproliferative small intestinal disease: case report and literature review.
Immunoproliferative small intestinal disease (IPSID) is a subtype of lymphoma of mucosa-associated lymphoid tissue. Notable for a high production of alpha-heavy chains, it is designated alpha-heavy-chain disease. IPSID is a debilitating disease that has a predilection for impoverished populations of developing countries. It has been documented primarily in subjects of Middle Eastern countries and thus was previously referred to as Mediterranean lymphoma. We report the case of a 42-year-old man from Senegal who presented with chronic diarrhea, dehydration, and weight loss. The endoscopic, pathologic, and serologic findings before, during, and after treatment with fludarabine phosphate are presented. We review the literature concerning current concepts on the etiology, pathogenesis, and management of IPSID.
Trotman
B W
BW
Department of Medicine, UMDNJ-University Hospital, Newark 07103-2406, USA.
Pavlick
A C
AC
Igwegbe
I C
IC
Goldstein
M M
MM
D000328:Adult; D004386:Duodenum / Q000473:pathology; D006801:Humans; D007161:Immunoproliferative Small Intestinal Disease / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis